Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
758 - In the PAAB Fair Balance guidance, for lowest level FB, it states "messages which do not relate to the healthcare product (e.g. disease information)". Question is: If the message does not relate to the product and only disease info, why would we require any FB at all? it is not advertising. Or could you provide an example for this scenario?
-
You’ll note that the “Scope” of the document states “This document applies only to healthcare professional advertising/promotions systems (APS) that require fair balance per PAAB code 2.1, 2.4, 3.5 and 7.3”.
Mention of the brand or branding elements, and discussion of disease content would suggest the therapeutic use without properly limiting to the specifics of the products indication. The brands indication and lowest level fair balance should be presented so as to accurately convey the limitations of use.
